Pure Ductal Carcinoma in Situ in The Male Breast: A Rare Entity

Pure ductal carcinoma in situ of male breast (DCIS) is extremely rare. Only a few cases have been reported until now. Its treatment is not wellestablished. Prognosis is as good as in women. In this study, we reported 3 cases of pure ductal carcinoma in situ in the male breast. The mean ageof DCIS patients was 58.3 years. The main symptom was a breast mass. The median size of the tumor was 25 mm. Two patients had an axillarylymph node. The left side was reached in 2 cases. All of the patients underwent mastectomy. The histopathological assessment showed papillary,cribriform, and comedocarcinoma in situ. There was no evidence of invasive carcinoma. In one case, the DCIS was associated with Paget'sdisease of the nipple. One patient received hormonotherapy. The time of follow-up ranged between 6 and 117 months. One patient developedan invasive recurrence.

🔖

Cite This Article

BOUBANI, M., KAMMOUN, S., JAIDANE, O., CHARGUI, R., RAHAL, K., SAKHRI, S., ADOUNI, O. (2022). Pure Ductal Carcinoma in Situ in The Male Breast: A Rare Entity. European Journal of Breast Health, Cilt: 16 - Sayı: 1, 77–80. https://ajindex.com/articles/510767

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (10)

Chern J, Liao L, Baraldi R, Tinney E, Hendershott K, Germaine P. Case Report: Ductal Carcinoma in Situ in the Male Breast. Case Rep Radiol 2012; 532527. (PMID: 23056988
Brents M, Hancock J. Ductal Carcinoma In situ of the Male Breast. Breast Care 2016; 11: 288290. (PMID: 27721718
Cutuli B, Dilhuydy JM, De Lafontan B, Berlie J, Lacroze M, Lesaunier F, Graic Y, Tortochaux J, Resbeut M, Lesimple T, Gamelin E, Campana F, Reme-Saumon M, Moncho-Bernier V, Cuilliere JC, Marchal C, De Gislain G, N’Guyen TD, Teissier E, Velten M. Ductal carcinoma in situ of the male breast. Analysis of 31 cases. Eur J Cancer 1997; 33: 3538. (PMID: 9071896
Coroneos CJ, Hamm C. Ductal carcinoma in situ in a 25-year-old man presenting with apparent unilateral gynecomastia. Curr Oncol 2010; 17: 133137. (PMID: 20697526
Doebar SC, Slaets L, Cardoso F, Giordano SH, Bartlett JM, Tryfonidis K, Dijkstra NH, Schröder CP, van Asperen CJ, Linderholm B, Benstead K, Dinjens WN, van Marion R, van Diest PJ, Martens JW, van Deurzen CH. Male breast cancer precursor lesions: analysis of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program. Mod Pathol 2017; 30: 509-518. (PMID: 28084333
Isley LM, Leddy RJ, Rumboldt T, Bernard JM. Asymptomatic Incidental Ductal Carcinoma in situ in a Male Breast Presenting with Contralateral Gynecomastia. J Clin Imaging Sci 2012; 2: 9. (PMID: 22530182
Deutsch M, Rosenstein MM. Ductal carcinoma in situ (DCIS) of the male breast treated by lumpectomy and breast irradiation. Clin Oncol (R Coll Radiol) 1998; 10: 204-205. (PMID: 9704187
Silverstein MJ, Lagios MD, Craig PH, Waisman JR, Lewinsky BS, Colburn WJ, Poller DN. A prognostic index for ductal carcinoma in situ of the breast. Cancer 1996; 77: 2267-2274. (PMID: 8635094
Silverstein, MJ. The University of Southern California/Van Nuys prognostic index for ductal carcinoma in situ of the breast. Am J Surg 2003; 186: 337-343. (PMID: 14553846
Cardoso F, Bartlett JMS, Slaets L, van Deurzen CHM, van Leeuwen-Stok E, Porter P, Linderholm B, Hedenfalk I, Schröder C7, Martens J, Bayani J, van Asperen C, Murray M, Hudis C, Middleton L, Vermeij J, Punie K, Fraser J, Nowaczyk M, Rubio IT, Aebi S, Kelly C, Ruddy KJ, Winer E, Nilsson C, Dal Lago L, Korde L, Benstead K, Bogler O, Goulioti T, Peric A, Litière S, Aalders KC, Poncet C, Tryfonidis K, Giordano SH. Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Progra